|Articles|March 20, 2023
Rapid and Direct Quantitation of AAV Capsids Using Octet® BLI
Author(s)Sartorius
BridgeBio Pharma, Inc., and REGENXBIO Inc. take a novel approach to AAV capsid titer quantification by using Octet® AAVX Biosensors to generate viral titer data.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
4
How Biopharma Navigates the 2026 Economic Shift
5